John G. Compton serves as Executive at 20/20 Biolabs, Inc., where they oversee executive responsibilities. Since joining the company, John G. Compton has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 19, 2026 involved exercising options for 7,669 shares valued at $0.
John G. Compton currently holds 14,335 shares of 20/20 Biolabs, Inc. (AIDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John G. Compton has been a net neutral trader of AIDX stock. They have purchased $0 and sold $0 worth of shares.
John G. Compton's most recent insider trade was on Feb 19, 2026, when they sold 7,669 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |